Excretion of norsteroids' phase II metabolites of different origin in human

Steroids

Volumn 74, Issue 3, 2009, Pages 350-358

  Guay, Claudiane ^a   Goudreault, Danielle ^a   Schänzer, Wilhem ^b   Flenker, Ulrich ^b   Ayotte, Christiane ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

19 norandrosterone; GC C IRMS; GC MS; Glucuronide; Offal; Sulfate

Indexed keywords

19 NORANDROSTERONE; 19 NOREPIANDROSTERONE GLUCURONIDE; 19 NOREPIANDROSTERONE SULFATE; 19 NORETIOCHOLANOLONE; NORSTEROID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHLETE; CONJUGATION; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; INGESTION; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLITE; NORMAL HUMAN; PORK; PREGNANCY; STEROID EXCRETION; URINALYSIS; URINARY EXCRETION;

ANIMALS; DESOXYCORTICOSTERONE; ESTRANES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; PREGNANCY; REPRODUCIBILITY OF RESULTS; SWINE;

SUIDAE;

EID: 61349156695     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2008.10.015     Document Type: Article

References (65)

1. Engel L.L., Alexander J., and Wheeler M. Urinary metabolites of administered 19-nortestosterone. J Biol Chem 231 (1958) 159-164
2. Massé R., Laliberté C., Tremblay L., and Dugal R. Gas chromatographic/mass spectrometric analysis of 19-nortestosterone urinary metabolites in man. Biomed Mass Spectrom 12 3 (1985) 115-121
3. Schänzer W. Metabolism of anabolic androgenic steroids. Clin Chem 42 7 (1996) 1001-1020
4. Kintz P., Cirimele V., and Ludes B. Norandrostérone et norétiocholanolone: les métabolites révélateurs. Acta Clin Belg Suppl Suppl. 1 (1999) 68-73
5. Schänzer W., Breidbach A., Geyer H., van Kuk C., Nolteernsting E., and Thevis M. Metabolism of nortestosterone, norandrostenedione and norandrostenediol. Identification of 3α-hydroxyestr-4-en-17-one glucuronide and 3α,16α-dihydroxy-5α-estran-17-one glucuronide and sulphate. In: Schänzer W., Geyer H., Gotzmann A., and Mareck-Engelke U. (Eds). Recent advances in doping analysis (7). 17th Cologne workshop on dope analysis 14th to 19th March 1999 (2000), Sport and Buch Strauss, Köln 155-174
6. Uralets V.P., and Gillette P.A. Over-the-Counter anabolic steroids 4-androsten-3,17-dione; 4-androsten-3α,17α-diol, and 19-nor-4-androstene-3,17-dione: excretion studies in men. J Anal Toxicol 23 5 (1999) 357-366
7. Uralets V.P., and Gillette P.A. Over-the-counter delta5 anabolic steroids 5-androsten-3,17-dione; 5-androsten-3α,17β-diol; dehydroepiandrosterone and 19-Nor-5-androstene-3,17-dione: excretion studies in men. J Anal Toxicol 24 3 (2000) 188-193
8. World Anti-Doping Code, List of Prohibited Substances 2008 available at http://www.wada-ama.org/en/prohibitedlist.ch2 (accessed June 2008).
9. Ayotte C. The significance of 19-norandrosterone findings in athletes' urine samples. B J Sport Med 40 Suppl 1 (2006) i25-i29
10. World Anti-doping Agency. International Standard for Laboratories, Technical Document TD2004MRPL, available at http://www.wada-ama.org/rtecontent/document/perf_limits_2.pdf (accessed June 2008).
11. Mareck-Engelke U., Schultze G., Geyer H., and Schänzer W. 19-Norandrosterone in pregnant woman. In: Schänzer W., Geyer H., Gotzmann A., and Mareck-Engelke U. (Eds). Recent advances in doping analysis (7). 17th Cologne workshop on dope analysis 14th to 19th March 1999 (2000), Sport and Buch Strauss, Köln 145-154
12. Dehennin L., Bonnaire Y., and Plou P. Urinary excretion of 19-norandrosterone of endogenous origin in man: quantitative analysis by chromatography-mass spectrometry. J Chromatogr B 721 2 (1999) 301-307
13. Le Bizec B., Monteau F., Gaudin I., and André F. Evidence for the present of endogenous 19-norandrosterone in human urine. J Chromatogr B 723 1-2 (1999) 157-172
14. Schmitt N., Flament M.M., Goubault C., Legros P., France Grenier-Loustalot M., and Denjean A. Nandrolone excretion is not increased by exhaustive exercise in trained athletes. Med Sci Sports Exerc 34 9 (2002) 1436-1439
15. Ciardi M., Ciccoli R., Barbarulo M.V., and Nicoletti R. Presence of norandrosterone in "normal" urine samples. In: Schänzer W., Geyer H., Gotzmann A., and Mareck-Engelke U. (Eds). Recent advances in doping analysis (6). 16th Cologne workshop on dope analysis 15th to 20th March 1998 (1999), Sport and Buch Strauss, Köln 97-104
16. Jeanneau T., Kintz P., Cirimele V., and Ludes B. Détermination des concentrations physiologiques de la norandrostérone et de la norétiocholanolone, métabolites urinaires de la nandrolone par CPG/SM. Toxicorama XI (1999) 25-29
17. Van Eenoo P., Delbeke F.T., De Jong F.H., and De Backer P. Endogenous origin of norandrosterone in female urine: indirect evidence for the production of 19-norsteroids as by-products in the conversion from androgen to estrogen. J Steroids Biochem Mol Biol 78 4 (2001) 351-357
18. Hemmersbach P., Hågensen A.H., and Misund J. Determination of urinary norandrosterone excretion in females during one menstrual cycle by gas chromatography/mass spectrometry. In: Schänzer W., Geyer H., Gotzmann A., and Mareck-Engelke U. (Eds). Recent advances in doping analysis (7). 17th Cologne workshop on dope analysis 14th to 19th March 1999 (2000), Sport and Buch Strauss, Köln 141-144
19. Khalil M., Morley P., Glasier M., Armstrong D., and Lang T. Formation of 4-oestren-3,17-dione (19-norandrostenedione) in porcine granulosa cells in vitro is inhibited by the aromatase inhibitor 4-hydroxyandrostenedione and the cytochrome P-450 inhibitors aminoglutethimide phosphate and ketoconazole. J Endocrinol 120 2 (1989) 251-260
20. Garrett W.M., Hoover D.J., Shackleton C.H.L., and Anderson L.D. Androgen metabolism by porcine granulosa cells during the process of luteinization in vitro: identification of 19-oic-androstenedione as a major metabolite and possible precursor for the formation of C18 Neutral Steroids. Endocrinology 129 6 (1991) 2941-2950
21. Graham-Laurence S., Amarneh B., White R.E., Peterson J.A., and Simpson E.R. A three-dimensional model of aromatase cytochrome P450. Protein Sci 4 6 (1995) 1065-1080
22. Moslemi S., Silberzahn P., and Gaillard J.-L. In vitro 19-norandrogen synthesis by equine placenta requires the participation of aromatase. J Endocrinol 144 3 (1995) 517-525
23. Kao Y.-C., Higashiyama T., Sun X., Okubo T., Yarborough C., Choi I., et al. Catalytic differences between porcine blastocyst and placental aromatase isozymes. Eur J Biochem 267 20 (2000) 6134-6139
24. Dehennin L., Jondet M., and Scholler R. Androgen and 19-norsteroid profiles in human preovulatory follicles from stimulated cycles: an isotope dilution-mass spectrometric study. J Steroid Biochem 26 3 (1987) 399-405
25. Reznik Y., Herrou M., Dehennin L., Lemaire M., and Leymarie P. Rising plasma levels of 19-nortestosterone throughout pregnancy: determination by radioimmunoassay and validation by gas chromatography-mass spectrometry. J Clin Endocr Metabol 64 5 (1987) 1086-1088
26. Reznik Y., Dehennin L., Coffin C., Mahoudeau J., and Leymarie P. Urinary nandrolone metabolites of endogenous origin in man: a confirmation by output regulation under human chorionic gonadotropin stimulation. J Clin Endocrinol Metab 86 (2001) 146-150
27. Ayotte, C. Nutritional supplements and doping controls. IAAF New Studies in Athletics 1999; 14:37-42 (http://www2.iaaf.org/TheSport/Science/Nsa.html).
28. Geyer H., Mareck-Engelke U., Reinhart U., Thevis M., and Schanzer W. Positive doping cases with norandrosterone after application of contaminated nutritional supplements. Deutsche Zeitschrift für Sportmedizin 51 11 (2000) 378-382
29. Geyer H., Mareck-Engelke U., Reinhart U., Thevis M., and Schanzer W. The analysis of "non-hormonal" nutritional supplements for prohormones. In: Schänzer W., Geyer H., Gotzmann A., and Mareck-Engelke U. (Eds). Recent advances in doping analysis, proceedings of the 19th Cologne workshop on dope analysis. Edition Sport (2001), Sport und Buch Strauβ, Cologne 63
30. Catlin D.H., Leder B.Z., Ahrens B., Starcevic B., Hatton C.K., Green G.A., et al. Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite. JAMA 284 20 (2000) 2618-2621
31. Ayotte C., Levesque J.F., Cléroux M., Lajeunesse A., Goudreault D., and Fakirian A. Sport nutritional supplements: quality and doping controls. Can J Appl Physiol 26 Suppl (2001) S120-S129
32. Kamber M., Baume N., Saugy M., and Rivier L. Nutritional supplements as a source for positive doping cases?. J Int Sport Nutr Exerc Metab 11 (2000) 258
33. Maughan R.J. Contamination of dietary supplements and positive drug tests in sport. J Sports Sci 23 9 (2005) 883-889
34. Grosse J., Anielski P., Hemmersbach P., Lund H., Mueller R.K., Rautenberg C., et al. Formation of 19-norsteroids by in situ demethylation of endogenous steroids in stored urine samples. Steroids 70 (2005) 499-506
35. World Anti-Doping Agency, Technical note. Stability of 19-norandrosterone findings in urine (2005).
36. Hebestreit M., Flenker U., Geyer H., Güntner U., Mareck U., Piper T., et al. Determination of the origin of urinary norandrosterone traces by gas chromatography combustion isotope ratio mass spectrometry. Analyst 131 September (9) (2006) 1021-1026
37. Ayotte C., Romiguière C., Fakirian A., Flenker U., Hebestreit M., Piper T., et al. The usefulness of GC/C/IRMS in determining the origin of low levels 19-NA: application in routine analysis. In: Schanzer W., Geyer H., Gotzmann A., and Mareck-Engelke U. (Eds). Recent advances in doping analysis (14), proceedings of the 24th Cologne workshop on dope analysis (2006), Sport & Buch Strauss, Cologne
38. Houghton E., Copsey J., Dumasia M.C., Haywood P.E., Moss M.S., and Teale P. The identification of C-18 neutral steroids in normal stallion urine. Biomed Mass Spectrom 11 2 (1984) 96-99
39. Benoit E., Garnier F., Courtot D., and Delatour P. Radioimmunoassay of 19-nortestosterone evidence of its secretion by the testis of the stallion. Ann Rech Vet 16 4 (1985) 379-383
40. Dintinger T., Gaillard J.-L., Zwain I., Bouhamidi R., and Silberzahn P. Synthesis and aromatization of 19-norandrogens in the stallion testis. J Steroid Biochem 32 4 (1989) 537-544
41. Debruyckere G., Van Peteghem C., De Brabander H., and Debackere M. Gas chromatographic-mass spectrometric confirmation of 19-nortestosterone in the urine of untreated boars-effect of the administration of Laurabolin. Vet Q 12 4 (1990) 246-250
42. Debruyckere G., and Van Peteghem C. Detection of 19-nortestosterone and its urinary metabolites in miniature pigs by gas chromatography-mass spectrometry. J Chromatogr B 564 2 (1991) 393-403
43. Vandenbroeck M., Van Vyncht G., Gaspar P., Dasnois C., Delahaut P., Pelzer G., et al. Identification and characterization of 19-nortestosterone in urine of meat-producing animals. J Chromatogr B 564 2 (1991) 405-412
44. Meyer H.H.D., Falckenberg D., and Janowski T. Evidence for the presence of endogenous 19-nortestosterone in the cow peripartum and in the neonatal calf. Acta Endocrinol 126 4 (1992) 369-373
45. Schwarzenberger F., Toole G.S., Christie H.L., and Raeside J.I. Plasma levels of several androgens and estrogens from birth to puberty in male domestic pigs. Acta Endocrinol 128 2 (1993) 173-177
46. De Brabander H., van Hende J., and Hendricks L. Endogenic nortestosterone in cattle?. Analyst 119 12 (1994) 2581-2585
47. Clouet A.-M., Le Bizec B., Montrade M.-P., Monteau F., and André F. Identification of endogenous 19-Nortestosterone in pregnant ewes by gas chromatography-mass spectrometry. Analyst 122 5 (1997) 471-474
48. Sterk S., Herbold H., Blokland M., van Rossum H., van Gikel L., and Stephany R. Nortestosterone: endogenous in urine of goats, sheep and mares?. Analyst 123 12 (1998) 2633-2636
49. Le Bizec B., Gaudin I., Monteau F., André F., Impens S., De Wash K., et al. Consequence of boar edible tissue consumption on urinary profile of nandrolone metabolites. I. Mass spectrometric detection and quantification of 19-norandrosterone and 19-noretiocholanolone in human urine. Rapid Commun Mass Spectrom 14 12 (2000) 1058-1065
50. Ayotte C., Goudreault D., and Charlebois A. Testing for natural and synthetic anabolic agents in human urine. J Chromatogr B 687 1 (1996) 3-25
51. Ayotte C., Goudreault D., Lajeunesse A., Cléroux M., Richard Y., Charlebois A., et al. GC/C/IRMS and GC/MS in "natural" steroids testing. In: Schänzer W., Geyer H., Gotzmann A., and Mareck-Engelke U. (Eds). Recent advances in doping analysis (9). 19th Cologne workshop on dope analysis 18th to 23rd March 2001 (2001), Sport and Buch Strauss, Köln 133-143
52. Lévesque J.-F., and Ayotte C. The oral administration of dhea: the efficiency of steroid profiling. In: Schänzer W., Geyer H., Gotzmann A., and Mareck-Engelke U. (Eds). Recent advances in doping analysis (7). 17th Cologne workshop on dope analysis 14th to 19th March 1999 (2000), Sport and Buch Strauss, Köln 213-221
53. Donike M., Rauth S., and Sample B. Excretion of ephedrine and endogenous steroids under conditions of controlled water intake and of urine diuresis. In: Donike M., Geyer H., Gotzmann A., Mareck-Engelke U., and Rauth S. (Eds). Recent advances in doping analysis. 10th Cologne workshop on dope analysis 7th to 12th June 1992 (1992), Sport and Buch Strauss, Köln 163-184
54. Uralets V.P., Gillette P.A., and Latven R.K. Occurrence of 19-nordehydro-androsterone/etiocholanolone in nandrolone positive specimens. In: Schänzer W., Geyer H., Gotzmann A., and Mareck-Engelke U. (Eds). Recent advances in doping analysis (4). 15th Cologne workshop on dope analysis 17th to 22nd March 1996 (1997), Sport and Buch Strauss, Köln 35-41
55. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Gramham-Lorence S., et al. Aromatase cytochrome P450, the enzyme responsible for estrogen synthesis. Endocr Rev 15 3 (1994) 342-355
56. Raeside J.I., Friendship R.M., and Vrablic O.E. Effects of castration on early postnatal development of male accessory sex glands in the domestic pig. Eur J Endocrinol 137 3 (1997) 287-292
57. De Wasch K., Le Bizec B., De Brabander H., André F., and Impens S. Consequence of boar edible tissue consumption on urinary profile of nandrolone metabolites. II. Identification and quantification of 19-norsteroids responsible for 19-norandrosterone and 19-noretiocholanolone excretion in human urine. Rapid Commun Mass Spectrom 15 16 (2001) 1442-1447
58. Mason P.M., Hall S.E., Gilmour I., Houghton E., Pillinger C., and Seymour M.A. The use of stable carbon isotope analysis to detect the abuse of testosterone in cattle. Analyst 123 12 (1998) 2405-2408
59. Ferchaud V., Le Bizec B., Monteau F., and André F. Determination of the exogenous character of testosterone in bovine urine by gas chromatography-combustion-isotope ratio mass spectrometry. Analyst 123 12 (1998) 2617-2620
60. Ferchaud V., Le Bizec B., Monteau F., and André F. Characterization of exogenous testosterone in livestock by gas chromatography/combustion/isotope ratio mass spectrometry: influence of feeding and age. Rapid Commun Mass Spectrom 14 8 (2000) 652-656
61. Prévost S., Nicol T., Monteau F., André F., and Le Bizec B. Gas chromatography/combustion/isotope ratio mass spectrometry to control the misuse of androgens in breeding animals: new derivatisation method applied to testosterone metabolites and precursors in urine samples. Rapid Commun Mass Spectrom 15 24 (2001) 2509-2514
62. Le Bizec B., Bryand F., Gaudin I., Monteau F., Poulain F., and André F. Endogenous nandrolone metabolites in human urine. Two-year monitoring of male professional soccer players. J Anal Toxicol 26 1 (2002) 43-47
63. Le Bizec B., Bryand F., Gaudin I., Monteau F., Poulain F., and André F. Endogenous nandrolone metabolites in human urine: preliminary results to discriminate between endogenous and exogenous origin. Steroids 67 2 (2002) 105-110
64. Shackleton C.H.L. Profiling Steroid Hormones and Urinary Steroids. J. Chromatogr 379 (1986) 91-156
65. Vestergaard P. The hydrolysis of conjugated neutral steroids in urine. Acta Endocrinol Suppl (Copenh) 217 (1978) 96